Target intelligence / Profile preview

Beta-1,3-glucuronyltransferase 3 pseudogene 1 (B3GAT3P1)

Target
B3GAT3P1
Molecular classification
Other (Pseudogene)
01

Overview

**Beta-1,3-glucuronyltransferase 3 pseudogene 1 (B3GAT3P1)** is a pseudogene and does not encode a functional protein or enzyme. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they arise from gene duplication or retrotransposition and typically lack the regulatory elements necessary for gene expression or have acquired disabling mutations. Thus, B3GAT3P1 has no known biological function, disease association, or role as a drug target or biomarker[3].\n\nSummary of evaluation:\n\n- **B3GAT3P1 (Beta-1,3-glucuronyltransferase 3 pseudogene 1)** is not an active gene and does not code for a functional protein. By definition, pseudogenes are not considered therapeutic targets and have no known molecular function or role in disease pathways. There is no evidence linking this pseudogene to any interacting drugs, mechanisms of action, disease associations, or biomarkers. The requested abbreviation (PSIGLCAT-I) is a synonym, but the molecule is not a drug-target or therapeutic receptor, enzyme, or transporter[3].

Other names
PSIGLCAT-IBeta-1,3-glucuronyltransferase 3 pseudogene 1B3GAT3P1

Beyond the preview

Go deeper on Beta-1,3-glucuronyltransferase 3 pseudogene 1 (B3GAT3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-1,3-glucuronyltransferase 3 pseudogene 1 (B3GAT3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call